HUP0203722A3 - Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use - Google Patents

Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use

Info

Publication number
HUP0203722A3
HUP0203722A3 HU0203722A HUP0203722A HUP0203722A3 HU P0203722 A3 HUP0203722 A3 HU P0203722A3 HU 0203722 A HU0203722 A HU 0203722A HU P0203722 A HUP0203722 A HU P0203722A HU P0203722 A3 HUP0203722 A3 HU P0203722A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
substituted phenyl
compositions containing
piperazine derivatives
piperazine
Prior art date
Application number
HU0203722A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HUP0203722A2 publication Critical patent/HUP0203722A2/hu
Publication of HUP0203722A3 publication Critical patent/HUP0203722A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0203722A 1999-12-30 2000-12-20 Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use HUP0203722A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901885 1999-12-30
PCT/DK2000/000721 WO2001049678A1 (en) 1999-12-30 2000-12-20 Substituted phenyl-piperazine derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
HUP0203722A2 HUP0203722A2 (hu) 2003-03-28
HUP0203722A3 true HUP0203722A3 (en) 2005-03-29

Family

ID=8108803

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203722A HUP0203722A3 (en) 1999-12-30 2000-12-20 Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use

Country Status (28)

Country Link
US (1) US6699864B2 (hu)
EP (1) EP1246816B1 (hu)
JP (1) JP2003519224A (hu)
KR (1) KR100790916B1 (hu)
CN (1) CN1230432C (hu)
AR (1) AR029428A1 (hu)
AT (1) ATE261959T1 (hu)
AU (1) AU2152101A (hu)
BG (1) BG65262B1 (hu)
BR (1) BR0016952A (hu)
CA (1) CA2395705C (hu)
CZ (1) CZ20022319A3 (hu)
DE (1) DE60009155T2 (hu)
EA (1) EA006071B1 (hu)
ES (1) ES2213634T3 (hu)
HU (1) HUP0203722A3 (hu)
IL (2) IL150241A0 (hu)
IS (1) IS2174B (hu)
MX (1) MXPA02006223A (hu)
NO (1) NO322666B1 (hu)
NZ (1) NZ519647A (hu)
PL (1) PL199351B1 (hu)
PT (1) PT1246816E (hu)
SK (1) SK9442002A3 (hu)
TR (2) TR200400645T4 (hu)
UA (1) UA72948C2 (hu)
WO (1) WO2001049678A1 (hu)
ZA (1) ZA200204814B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen
UA81300C2 (en) * 2003-04-04 2007-12-25 Lundbeck & Co As H Derivates of 4-(2-fenilsulfanilfenil)-1,2,3,6-tetrahydropiridin as retarding agents of serotonin recapture
AU2004226838B8 (en) 2003-04-04 2009-06-11 H. Lundbeck A/S 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
MXPA06007172A (es) 2003-12-23 2006-08-23 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-bencilamina como ssri.
SE0400441D0 (sv) 2004-02-25 2004-02-25 Active Biotech Ab Novel Benzofurans and Indols
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
EP2044043B2 (en) 2006-06-16 2021-03-03 H. Lundbeck A/S 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine hydrobromide as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
AU2008310883A1 (en) * 2007-10-09 2009-04-16 Hamann, Mark T Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter
CA2718138A1 (en) * 2008-03-14 2009-09-17 Timo Heinrich Azaindole compounds for treatment of central nervous system disorders
CN105283442B (zh) * 2013-04-04 2018-04-13 斯洛文尼亚莱柯制药股份有限公司 用于合成1‑(2‑((2,4‑二甲基苯基)硫代)苯基)哌嗪的方法
WO2015169180A1 (en) * 2014-05-04 2015-11-12 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods and use thereof
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
WO2017012579A1 (zh) * 2015-07-23 2017-01-26 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
US11285153B2 (en) 2017-09-29 2022-03-29 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof
CN111518012A (zh) * 2020-05-27 2020-08-11 中国药科大学 含苯硫醚结构的化合物或其药学上可接受的盐、制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2138865A1 (de) * 1970-08-15 1973-02-22 Sumitomo Chemical Co 3-indolylpiperazine, verfahren zu ihrer herstellung und arzneimittel
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1994024105A1 (en) * 1993-04-15 1994-10-27 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
FR2712591B1 (fr) 1993-11-19 1996-02-09 Pf Medicament Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
WO1997019039A1 (en) 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.
WO2000077519A1 (en) 1999-06-15 2000-12-21 Aventis Pharmaceuticals Products Inc. Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
EP1246819A1 (en) * 1999-12-30 2002-10-09 H. Lundbeck A/S A method for the preparation of substituted benzene derivatives

Also Published As

Publication number Publication date
EP1246816A1 (en) 2002-10-09
EP1246816B1 (en) 2004-03-17
PT1246816E (pt) 2004-08-31
PL355539A1 (en) 2004-05-04
US20030125320A1 (en) 2003-07-03
IS6420A (is) 2002-06-13
WO2001049678A9 (en) 2002-10-10
KR100790916B1 (ko) 2008-01-03
IL150241A (en) 2008-12-29
CA2395705A1 (en) 2001-07-12
EA200200732A1 (ru) 2003-02-27
ATE261959T1 (de) 2004-04-15
PL199351B1 (pl) 2008-09-30
CN1437597A (zh) 2003-08-20
CN1230432C (zh) 2005-12-07
US6699864B2 (en) 2004-03-02
BR0016952A (pt) 2002-10-08
NO20023146D0 (no) 2002-06-28
AU2152101A (en) 2001-07-16
IL150241A0 (en) 2002-12-01
ES2213634T3 (es) 2004-09-01
EA006071B1 (ru) 2005-08-25
AR029428A1 (es) 2003-06-25
NZ519647A (en) 2004-02-27
TR200201683T2 (tr) 2002-12-23
DE60009155T2 (de) 2005-01-05
HUP0203722A2 (hu) 2003-03-28
WO2001049678A1 (en) 2001-07-12
CZ20022319A3 (cs) 2002-10-16
ZA200204814B (en) 2003-08-27
BG65262B1 (bg) 2007-10-31
KR20020063287A (ko) 2002-08-01
JP2003519224A (ja) 2003-06-17
DE60009155D1 (de) 2004-04-22
IS2174B (is) 2006-11-15
NO322666B1 (no) 2006-11-13
UA72948C2 (uk) 2005-05-16
BG106930A (en) 2003-04-30
CA2395705C (en) 2006-10-17
TR200400645T4 (tr) 2004-06-21
SK9442002A3 (en) 2002-11-06
NO20023146L (no) 2002-06-28
MXPA02006223A (es) 2002-12-05

Similar Documents

Publication Publication Date Title
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0203403A3 (en) New imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
HUP0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0301722A3 (en) Pyrimidine derivatives, pharmaceutical compositions containing them and their use
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0202795A3 (en) Pyrimidine and pyrazine derivatives, pharmaceutical compositions containing them and their use
HUP0200308A2 (en) Quinolinecarboxamides as antiviral agents, pharmaceutical compositions containing them and their use
HUP0400540A3 (en) 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
HUP0200155A3 (en) Thioamide derivatives, pharmaceutical compositions containing them and their use
HUP0303082A3 (en) Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
HUP0200996A3 (en) Amine derivatives, pharmaceutical compositions containing them and their use
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0203722A3 (en) Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use
HUP0105073A3 (en) 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees